Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study

JOURNAL ARTICLE published March 2022 in Anticancer Research

Authors: NOBUKI FURUBAYASHI | FUTOSHI MOROKUMA | TOSHIHISA TOMODA | YOSHIFUMI HORI | TAKAHITO NEGISHI | AKIHIRO MIURA | HIROKI KOMORI | KENTARO KUROIWA | MOTONOBU NAKAMURA